Host Audrey Neff sits down with Chase Howard, attorney at Florida Healthcare Law Firm, to unpack the basis for recent legal action pertaining to semaglutide taken against several U.S.-based practices, as well as tips for effectively marketing compounded vs. brand name GLP-1 medications. The pair also dive into the top compliance issues practices face when either opening an IV therapy clinic from the ground up or when adding IV therapy services into an existing practice model. Thinking of offering these services? This is an episode you don't want to miss.